ALLMedicine™ Cardiogenic Shock Center

Sep 15th, 2021 - Identification of patients with cardiogenic shock and right ventricle (RV) dysfunction who may require biventricular rather than isolated left ventricular (LV) support remains challenging. In this setting, rigorous hemodynamic evaluation of bivent...

Sep 15th, 2021 - COVID-19 has a broad spectrum of cardiac manifestations, and cardiac tamponade leading to cardiogenic shock is a rare presentation. A 30-year-old man with a history of COVID-19-positive, reverse transcription polymerase chain reaction (RT-PCR) don...

Sep 14th, 2021 - Background There is increasing utilization of cardiogenic shock treatment algorithms. The cornerstone of these algorithms is the use of invasive hemodynamic monitoring (IHM). We sought to compare the in-hospital outcomes in patients who received I...

Sep 10th, 2021 - A Mouse model of cardiogenic shock.|2021|Wang Y,Polten F,Jäckle F,Korf-Klingebiel M,Kempf T,|

Sep 9th, 2021 - We evaluate the effects of paroxysmal arrhythmia on the hospital outcomes of patients admitted with cirrhosis. : 2011-2017 National Inpatient Sample was used to isolate patients with decompensated/compensated cirrhosis, stratified by paroxysmal ar...

Sep 2nd, 2021 - The present is a multicenter, observational, retrospective study. All consecutive patients admitted with a diagnosis of AHF to the Cardiothoracovascular Departments of the ASST Grande Ospedale Metropolitano Niguarda (Milan), ASST Ospedale Papa Gio...

Jun 30th, 2021 - This is a pilot, multinational, multicenter, randomized, double-blind, placebo-controlled, safety and efficacy study. Subjects will consist of males or females 18 to 85 years of age hospitalized for ADHF with persistent hypotension (systolic blood...

Apr 13th, 2021 - STUDY OBJECTIVE The objective of the study is to estimate the frequency of cardiac arrhythmias and characterize the mode of death in patients with the novel coronavirus disease (SARS-CoV-2; COVID-19). The study will also evaluate the long term car...

Jun 9th, 2020 - Cardiogenic shock (CS) is a medical emergency and a frequent cause of death. CS can be complicated and/or precipitated by mitral regurgitation (MR). The efficacy of percutaneous treatment of MR in patients with cardiogenic shock is unknown. The ai...

Mar 26th, 2020 - Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a temporary mechanical circulatory support that has been increasingly used over the last decade to restore and maintain adequate end-organ perfusion, with data suggesting improvement i...

May 12th, 2021 - Although the ISCHEMIA trial is a touchstone in the management of patients with stable ischemic heart disease (SIHD), its population does not reflect most patients seen in US practice today, new research suggests. The 2019 landmark trial challenged...

Apr 29th, 2021 - What started as an attempt to standardize care for acute myocardial infarction (MI) with cardiogenic shock at a handful of Detroit-area hospitals has led to markedly better survival rates than the traditional flip of a coin in a nationwide analysi...

Dec 10th, 2020 - NEW YORK (Reuters Health) - Patients in cardiogenic shock are more likely to survive when treated in an LVAD center, a large observational study suggests. "A multidisciplinary approach to the management of cardiogenic shock, with collaboration amo...

Oct 22nd, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19–positive patients undergoing an invasive strategy for acute coronary syndrome presented hours later than uninfected historical controls, ...

Oct 22nd, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19–positive patients undergoing an invasive strategy for acute coronary syndrome presented hours later than uninfected historical controls, ...